Black Diamond Therapeutics
Erika Jones serves as Black Diamond’s Vice President of Finance and Principal Accounting Officer and is a member of the Executive Leadership Team. Erika joined the Company in 2019, bringing more than 15 years of financial management, SEC reporting and operational leadership experience with life science companies to the role. Prior to joining the Black Diamond, she led the SEC reporting and technical accounting functions as the Director of Finance at Axcella Health Inc., a publicly traded biotechnology company. Erika began her career in public accounting at Ernst & Young, LLP.
Erika holds both a B.S. and Master’s degree in accounting from Miami University and is a Certified Public Accountant in the Commonwealth of Massachusetts.
This person is not in any offices
Black Diamond Therapeutics
3 followers
Black Diamond Therapeutics is a leading venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes.